Cite
HARVARD Citation
Pan, T. et al. (2018). Addition of histone deacetylase inhibitors does not improve prognosis in patients with myelodysplastic syndrome and acute myeloid leukemia compared with hypomethylating agents alone: A systematic review and meta-analysis of seven prospective cohort studies. Leukemia research. pp. 13-24. [Online].